324 related articles for article (PubMed ID: 16850809)
1. [Chronic inflammatory bowel diseases. Proven and innovative in the treatment].
MMW Fortschr Med; 2006 Jun; 148(24):43. PubMed ID: 16850809
[No Abstract] [Full Text] [Related]
2. [Probiotics in chronic inflammatory bowel disease].
Böhm S; Kruis W
MMW Fortschr Med; 2006 Aug; 148(35-36):30-4. PubMed ID: 16995360
[TBL] [Abstract][Full Text] [Related]
3. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
[No Abstract] [Full Text] [Related]
4. [Ulcerative colitis. Acute episode].
Reissmann A; Bischoff SC; Fleig W
Z Gastroenterol; 2004 Sep; 42(9):994-8. PubMed ID: 15455271
[No Abstract] [Full Text] [Related]
5. [5-aminosalicylic acid and chronic inflammatory bowel diseases in children].
Klotz U
Klin Padiatr; 1995; 207(5):285-7. PubMed ID: 7500605
[TBL] [Abstract][Full Text] [Related]
6. Controversies with aminosalicylates in inflammatory bowel disease.
Lim WC; Hanauer SB
Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic principles for chronic inflammatory bowel disease].
Binder V; Munkholm P
Ugeskr Laeger; 2001 Jan; 163(1):16-21. PubMed ID: 11586666
[TBL] [Abstract][Full Text] [Related]
8. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
MMW Fortschr Med; 2009 May; 151(19):38-9. PubMed ID: 19827443
[No Abstract] [Full Text] [Related]
9. [News from the Cochrane Library: Maintenance of remission in ulcerative colitis].
Timmer A
Z Gastroenterol; 2007 May; 45(5):395-6. PubMed ID: 17503319
[No Abstract] [Full Text] [Related]
10. Medical treatment of inflammatory bowel disease.
Singhal A; Kar P
J Assoc Physicians India; 1995 Sep; 43(9):627-31. PubMed ID: 8773067
[No Abstract] [Full Text] [Related]
11. [Ulcerative colitis. Maintenance therapy].
Kruis W; Schreiber S
Z Gastroenterol; 2004 Sep; 42(9):1011-4. PubMed ID: 15455275
[No Abstract] [Full Text] [Related]
12. Trends in inflammatory bowel disease therapy.
Thomson AB; Williams CN
Can J Gastroenterol; 1999 Nov; 13(9):775-6. PubMed ID: 10633831
[No Abstract] [Full Text] [Related]
13. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
[TBL] [Abstract][Full Text] [Related]
14. [Drug therapy of inflammatory bowel diseases].
Silvennoinen J; Niemelä S
Duodecim; 1999; 115(20):2233-8. PubMed ID: 11973927
[No Abstract] [Full Text] [Related]
15. [Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease].
Marteau P; Seksik P
Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C94-7. PubMed ID: 11787388
[No Abstract] [Full Text] [Related]
16. Review article: induction therapy for patients with active ulcerative colitis.
Travis SP
Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 1():10-6. PubMed ID: 16939424
[TBL] [Abstract][Full Text] [Related]
17. The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.
Cohen HD; Das KM
J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S150-4. PubMed ID: 16885699
[TBL] [Abstract][Full Text] [Related]
18. Rational selection of oral 5-aminosalicylate formulations and prodrugs for the treatment of ulcerative colitis.
Sandborn WJ
Am J Gastroenterol; 2002 Dec; 97(12):2939-41. PubMed ID: 12492172
[No Abstract] [Full Text] [Related]
19. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
Sandborn WJ
Rev Gastroenterol Disord; 2006; 6(2):97-105. PubMed ID: 16699478
[TBL] [Abstract][Full Text] [Related]
20. MMX mesalamine.
Baker DE
Rev Gastroenterol Disord; 2006; 6(3):146-52. PubMed ID: 16957657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
